The procedural duration typically ranges from 15 to 30 minutes, exclusive of the preparatory time required for topical anesthesia.

Results are visible immediately after the treatment.

Therapeutic longevity typically ranges from 9 to 18 months, subject to variance based on rheological properties of the selected filler and individual physiological determinants.

Patients typically resume normal daily activities immediately post-procedure, subject to transient, mild erythema or edema.

While minor discomfort may be experienced, numerous formulations incorporate local anesthetic agents to optimize patient comfort during administration.

As with all minimally invasive medical interventions, injectable treatments present inherent clinical risks. Common transient adverse events include localized ecchymosis and edema resulting from microvascular disruption, which typically resolve spontaneously within 4 to 7 days. The most severe complication is vascular occlusion, wherein intra-arterial embolization blocks perfusion, potentially causing tissue necrosis or blindness. While frequently associated with nasal augmentations due to the rich vascular network communicating with ophthalmic structures, inadvertent intra-arterial injection in any facial region can precipitate retrograde embolization to the optic artery. These severe complications are largely preventable through comprehensive knowledge of facial vascular anatomy. Consequently, administration by an experienced medical professional is paramount, particularly as over 90% of recorded complications stem from unauthorized, non-medical providers.